Breast Cancer Risk
Oncology
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Precision BioSciencesDURHAM, NC
1 programBreast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow upN/A1 trial
Active Trials
Ambry GeneticsCA - Aliso Viejo
1 programClinical Implementation of a Polygenic Risk Score (PRS) for Breast CancerN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Precision BioSciencesBreast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow up
Ambry GeneticsClinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
Clinical Trials (2)
Total enrollment: 10,000 patients across 2 trials
NCT05848856Precision BioSciencesBreast Cancer, Cardiometabolic, Cardiovascular Risk Screening and Follow up
The RISC Registry--Risk Informed Screening Registry
Start: Sep 2024Est. completion: Sep 203510,000 patients
N/ANot Yet Recruiting
Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
Start: Sep 2018Est. completion: Nov 2020
N/ACompleted
Related Jobs in Oncology
Cell Therapy Account Manager(北陸)
Gilead Sciences
Japan - Tokyo
Just now
Senior Director of Clinical Operations
Arvinas
Remote
1h ago
Specialist, Quality Assurance
Umoja Biopharma
Louisville, Colorado, United States
3h ago
$85K - $105K/yr
Senior Facilities Technician
Umoja Biopharma
Louisville, Colorado, United States
3h ago
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
7h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space